Understanding how a protein affects immune signaling in blood cells

Regulation of Protein Kinase C Theta by Phosphorylation

NIH-funded research University of California, San Diego · NIH-11056895

This study is looking at how certain changes in a protein called PKCθ, which helps control immune responses in blood cells, can affect its activity, with the hope of finding better ways to treat autoimmune diseases and blood cancers.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11056895 on NIH RePORTER

What this research studies

This research investigates the role of phosphorylation in regulating the activity of protein kinase C Theta (PKCθ), a key player in immune signaling found in blood cells. By examining how specific phosphorylation sites influence PKCθ's function, the study aims to uncover mechanisms that could lead to better understanding and treatment of autoimmune diseases and blood cancers. The research employs advanced techniques such as phosphoproteomics to analyze changes in PKCθ in response to cellular stimulation. Patients may benefit from insights gained into how immune responses can be modulated in various conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with autoimmune diseases or blood disorders.

Not a fit: Patients with conditions unrelated to immune signaling or blood cell function may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating autoimmune diseases and blood cancers.

How similar studies have performed: Previous research has shown promising results in understanding immune signaling pathways, suggesting that this approach could yield valuable insights.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseasesautoimmune disorderautoimmunity disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.